iANTHUS CAPITAL HOLDINGS (ITHUF) Non-Current Deferred Tax Liability (2020 - 2024)

iANTHUS CAPITAL HOLDINGS's (ITHUF) quarterly Non-Current Deferred Tax Liability came in at $15.8 million in Q3 2024, down 33.51% year-on-year from $23.8 million in Q4 2023, and down 9.55% quarter-over-quarter from $17.5 million in Q2 2024.

iANTHUS CAPITAL HOLDINGS (ITHUF) Non-Current Deferred Tax Liability (2020 - 2024) Analysis & Trends

iANTHUS CAPITAL HOLDINGS has disclosed Non-Current Deferred Tax Liability across 5 years of filings, most recently posting $15.8 million for Q3 2024.

  • Non-Current Deferred Tax Liability for Q3 2024 came in at $15.8 million, down 33.51% year-over-year; the trailing twelve-month figure through Sep 2024 was $15.8 million (down 33.51% YoY), and the FY2023 annual result was $20.4 million, down 14.29% from the prior year.
  • Non-Current Deferred Tax Liability came in at $15.8 million for Q3 2024 at iANTHUS CAPITAL HOLDINGS, down from $17.5 million in the prior quarter.
  • In the past five years, Non-Current Deferred Tax Liability ranged from a high of $37.6 million in Q4 2020 to a low of $15.8 million in Q3 2024.
  • The 5-year median for Non-Current Deferred Tax Liability is $25.7 million (2021), against an average of $26.4 million.
  • Across the five-year window, Non-Current Deferred Tax Liability slipped 1.66% in 2022 and slumped 33.51% in 2024, its largest moves.
  • iANTHUS CAPITAL HOLDINGS's Non-Current Deferred Tax Liability stood at $37.6 million in 2020, then decreased by 26.89% to $27.5 million in 2021, then dropped by 13.42% to $23.8 million in 2022, then declined by 14.29% to $20.4 million in 2023, then declined by 22.59% to $15.8 million in 2024.
  • The last three Non-Current Deferred Tax Liability figures came in at $15.8 million (Q3 2024), $17.5 million (Q2 2024), and $17.9 million (Q1 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn
10 iANTHUS CAPITAL HOLDINGS - - 15.92 Mn

Historic Data

Download Data
DateValue
Sep 30, 2024 15.80 Mn
Sep 30, 2024 15.80 Mn
Jun 30, 2024 17.47 Mn
Jun 30, 2024 17.47 Mn
Mar 31, 2024 17.91 Mn
Mar 31, 2024 17.91 Mn
Dec 31, 2023 20.41 Mn
Dec 31, 2023 20.41 Mn
Sep 30, 2023 23.76 Mn
Sep 30, 2023 23.76 Mn
Jun 30, 2023 23.76 Mn
Jun 30, 2023 23.76 Mn
Mar 31, 2023 23.78 Mn
Mar 31, 2023 23.78 Mn
Dec 31, 2022 23.82 Mn
Dec 31, 2022 23.82 Mn
Sep 30, 2022 31.60 Mn
Sep 30, 2022 31.60 Mn
Jun 30, 2022 31.60 Mn
Jun 30, 2022 31.60 Mn